Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Xinfu Sues Xinfa For Patent Infringement

This article was originally published in PharmAsia News

Executive Summary

Xinfu Pharm, the number one global supplier of calcium D-pantothenate with an annual output of 6,500 tons, now faces serious competition from Shandong Xinfa Pharmaceutical. The latter's output ballooned dramatically from 600 tons to 5,000 tons over the last two years. Xinfu has filed a lawsuit against Xinfa, claiming that its rival's meteoric rise stems from infringement of Xinfu's patented technology. In response, Xinfa issued a legal declaration stating that the new technique was developed by its own researchers based on Japan Daiichi's patent. Insiders reveal that the case boils down to the world's two largest calcium D-pantothenate producers slugging it out for the lucrative market. (Click here for more - Chinese language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068443

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel